Viewing nowAtorTin M Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201502990 · Approved 2015.05.19 · Insurance code 622802470
Improvement of hyperlipidemia in adults and children; prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. It particularly reduces the risk of myocardial infarction, stroke, vascular surgeries, and stable angina in adults with various risk factors for coronary heart disease and in patients with type 2 diabetes. It also contributes to the reduction of risk of non-fatal myocardial infarction, stroke, vascular surgeries, heart failure hospitalization, and angina in patients with confirmed heart disease. It is used to treat hyperlipidemia by effectively lowering total cholesterol and LDL-cholesterol levels in patients with primary hypercholesterolemia and dyslipidemia, while increasing good HDL-cholesterol levels. It is also used as an adjunct to diet in pediatric patients with heterozygous familial hypercholesterolemia to reduce LDL-cholesterol levels. This medication is used to reduce the risk of cardiovascular disease and improve blood lipid levels.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin, and may take it at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only if a reduction in LDL cholesterol of 45% or more is required). This medicine is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking treatment goals and response into account. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is required. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose of this medicine is 10 mg per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be appropriately adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle problems, so if there are severe muscle pain or weakness, or if creatine kinase levels are significantly elevated, use should be stopped immediately. Additionally, in patients at risk for severe myopathy or rhabdomyolysis, the use of this medication should be interrupted temporarily or administered with caution. This medication should not be used in patients with certain liver diseases or muscle disorders, in women who are pregnant or may become pregnant, in nursing women, in children under 10 years old, and in patients taking certain medications. Caution should be taken when administering this medication to patients with a history of alcoholism, liver disease, impaired kidney function, hypothyroidism, muscle disorders, and elderly patients over 70 years old. Regular check-ups are necessary as liver function abnormalities or muscle-related adverse symptoms may occur during treatment with this medication, and patients should consult a doctor immediately if abnormal symptoms appear. This medication may interact with other drugs, so if there are other medications being taken, it is essential to inform the physician or pharmacist and use it with caution. Pregnant or nursing women should not take this medication, and women of childbearing age should use appropriate contraception while taking this medication. Elderly patients or those with impaired kidney function may have an increased risk of myopathy when using this medication, requiring additional caution. In cases of overdose, there is no specific antidote, and appropriate treatment should be administered according to the symptoms; the medication should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air ingress and is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White, round, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.